Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Messori

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Pharmacology|January 1, 1996
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancerA Messori, P Becagli, S Trippoli, et al.
Anti-Cancer Drugs|December 29, 2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolA Messori, F Cattel, S Trippoli, et al.
Cancer|June 1, 1997
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysisA Messori, M Cecchi, P Becagli, et al.
Acta Europaea Fertilitatis|March 1, 1986
Cervical cap homologous artificial insemination (AIH): the University of Florence experienceI Noci, E Chelo, G Scarselli, et al.
Acta Neurologica Scandinavica|August 17, 2006
Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?G Zaccara, A Messori, M Cincotta, et al.
Neuroradiology|October 28, 2003
Is haemosiderin visible indefinitely on gradient-echo MRI following traumatic intracerebral haemorrhage?A Messori, G Polonara, C Mabiglia, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2013
Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovirD Maratea, V Fadda, S Trippoli, et al.
Anti-Cancer Drugs|January 7, 1999
Treatments for newly diagnosed advanced ovarian cancer: analysis of survival data and cost-effectiveness evaluationA Messori, S Trippoli, P Becagli, et al.
Bone Marrow Transplantation|February 1, 1994
Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysisA Messori, R Rampazzo, G Scroccaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Cost-effectiveness of irinotecan in advanced colorectal cancerS Trippoli, M Vaiani, F Cattel, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Pharmacology|January 1, 1996
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancerA Messori, P Becagli, S Trippoli, et al.
Anti-Cancer Drugs|December 29, 2000
Survival in patients with metastatic breast cancer: analysis of randomized studies comparing oral aromatase inhibitors versus megestrolA Messori, F Cattel, S Trippoli, et al.
Cancer|June 1, 1997
Pharmacoeconomic profile of paclitaxel as a first-line treatment for patients with advanced ovarian carcinoma. A lifetime cost-effectiveness analysisA Messori, M Cecchi, P Becagli, et al.
Acta Europaea Fertilitatis|March 1, 1986
Cervical cap homologous artificial insemination (AIH): the University of Florence experienceI Noci, E Chelo, G Scarselli, et al.
Acta Neurologica Scandinavica|August 17, 2006
Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?G Zaccara, A Messori, M Cincotta, et al.
Neuroradiology|October 28, 2003
Is haemosiderin visible indefinitely on gradient-echo MRI following traumatic intracerebral haemorrhage?A Messori, G Polonara, C Mabiglia, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2013
Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovirD Maratea, V Fadda, S Trippoli, et al.
Anti-Cancer Drugs|January 7, 1999
Treatments for newly diagnosed advanced ovarian cancer: analysis of survival data and cost-effectiveness evaluationA Messori, S Trippoli, P Becagli, et al.
Bone Marrow Transplantation|February 1, 1994
Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysisA Messori, R Rampazzo, G Scroccaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Cost-effectiveness of irinotecan in advanced colorectal cancerS Trippoli, M Vaiani, F Cattel, et al.
Pageof 18